Vivo Capital LLC Purchases New Stake in Anthem, Inc. $ANTX

Vivo Capital LLC purchased a new stake in shares of Anthem, Inc. (NASDAQ:ANTX) in the 1st quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor purchased 3,153,640 shares of the company’s stock, valued at approximately $10,785,000. Anthem accounts for approximately 0.9% of Vivo Capital LLC’s holdings, making the stock its 29th largest holding. Vivo Capital LLC owned about 0.09% of Anthem at the end of the most recent reporting period.

A number of other hedge funds have also recently modified their holdings of the company. Commodore Capital LP acquired a new stake in Anthem in the first quarter valued at $7,981,000. Spruce Street Capital LP acquired a new position in shares of Anthem during the 1st quarter worth $5,576,000. Ally Bridge Group NY LLC purchased a new position in shares of Anthem in the 1st quarter valued at about $1,800,000. Bank of America Corp DE increased its holdings in shares of Anthem by 2.2% in the 1st quarter. Bank of America Corp DE now owns 393,702 shares of the company’s stock valued at $1,346,000 after purchasing an additional 8,390 shares in the last quarter. Finally, ADAR1 Capital Management LLC acquired a new stake in shares of Anthem in the first quarter valued at about $47,000. Hedge funds and other institutional investors own 90.47% of the company’s stock.

Anthem Stock Up 6.2%

Shares of ANTX stock opened at $5.33 on Friday. Anthem, Inc. has a fifty-two week low of $1.00 and a fifty-two week high of $6.91. The stock has a market cap of $191.99 million, a P/E ratio of -4.85 and a beta of -0.99. The business has a fifty day simple moving average of $4.67 and a 200-day simple moving average of $3.49.

Anthem (NASDAQ:ANTX) last released its quarterly earnings results on Monday, May 11th. The company reported ($0.29) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.23) by ($0.06).

Analysts Set New Price Targets

ANTX has been the topic of a number of research analyst reports. Weiss Ratings reissued a “sell (d-)” rating on shares of Anthem in a report on Monday, July 6th. Leerink Partners raised shares of Anthem from a “market perform” rating to an “outperform” rating and set a $9.00 target price for the company in a report on Thursday, May 14th. Wall Street Zen upgraded shares of Anthem from a “sell” rating to a “hold” rating in a research report on Sunday, June 14th. Finally, Guggenheim assumed coverage on Anthem in a research note on Monday, July 20th. They set a “buy” rating and a $9.00 price target on the stock. Two analysts have rated the stock with a Buy rating and one has issued a Sell rating to the stock. Based on data from MarketBeat, the company currently has a consensus rating of “Hold” and an average price target of $9.00.

Anthem Profile

Anthem, Inc, through its subsidiaries, operates as a health benefits company in the United States. It operates through three segments: Commercial & Specialty Business, Government Business, and Other. The company offers a spectrum of network-based managed care health benefit plans to large and small group, individual, Medicaid, and Medicare markets. Its managed care plans include preferred provider organizations; health maintenance organizations; point-of-service plans; traditional indemnity plans and other hybrid plans, such as consumer-driven health plans; and hospital only and limited benefit products.